Abstract
A series of nine N'-(E)-heteroaromatic-pyrazine-2-carbohydrazide derivatives (5a-f and 6a-c) have been synthesized and evaluated against M. tuberculosis ATCC 27294 using the micro plate Alamar Blue assay (MABA), being the activities expressed as the minimum inhibitory concentration (MIC) in μg/ml. Compounds 5a and 5f exhibited potent activities (3.12 and 50μg/mL, respectively) when compared to the first line drug pyrazinamide (MIC > 100 μg/mL). Afterwards, these compounds were evaluated for their cell viabilities in non-infected and infected macrophages with Mycobaterium bovis Bacillus Calmette-Guerin (BCG) and 5f was not cytotoxic to host cells in the effective concentration to inhibit the growth of M. tuberculosis.
Keywords: Pyrazine, tuberculosis, drugs, N'-(E)-heteroaromatic-pyrazine-2-carbohydrazide, M. tuberculosis, Alamar Blue assay, minimum inhibitory concentration, macrophages, Mycobaterium bovis, Bacillus Calmette-Guerin
Medicinal Chemistry
Title: Synthesis and Antimycobacterial Evaluation of N-(E)-heteroaromaticpyrazine-2-carbohydrazide Derivatives
Volume: 7 Issue: 3
Author(s): C. H. S. Lima, M. G. M. O. Henriques, A. L. P. Candea, M. C. S. Lourenco, F. A. F. M. Bezerra, M. L. Ferreira, C. R. Kaiser and M. V. N. de Souza
Affiliation:
Keywords: Pyrazine, tuberculosis, drugs, N'-(E)-heteroaromatic-pyrazine-2-carbohydrazide, M. tuberculosis, Alamar Blue assay, minimum inhibitory concentration, macrophages, Mycobaterium bovis, Bacillus Calmette-Guerin
Abstract: A series of nine N'-(E)-heteroaromatic-pyrazine-2-carbohydrazide derivatives (5a-f and 6a-c) have been synthesized and evaluated against M. tuberculosis ATCC 27294 using the micro plate Alamar Blue assay (MABA), being the activities expressed as the minimum inhibitory concentration (MIC) in μg/ml. Compounds 5a and 5f exhibited potent activities (3.12 and 50μg/mL, respectively) when compared to the first line drug pyrazinamide (MIC > 100 μg/mL). Afterwards, these compounds were evaluated for their cell viabilities in non-infected and infected macrophages with Mycobaterium bovis Bacillus Calmette-Guerin (BCG) and 5f was not cytotoxic to host cells in the effective concentration to inhibit the growth of M. tuberculosis.
Export Options
About this article
Cite this article as:
H. S. Lima C., G. M. O. Henriques M., L. P. Candea A., C. S. Lourenco M., A. F. M. Bezerra F., L. Ferreira M., R. Kaiser C. and V. N. de Souza M., Synthesis and Antimycobacterial Evaluation of N-(E)-heteroaromaticpyrazine-2-carbohydrazide Derivatives, Medicinal Chemistry 2011; 7 (3) . https://dx.doi.org/10.2174/157340611795564303
DOI https://dx.doi.org/10.2174/157340611795564303 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hydroxypyridinone Derivatives: A Fascinating Class of Chelators with Therapeutic Applications - An Update
Current Medicinal Chemistry Data Analysis and Mapping of Research Interest in Clinical Trials of Tuberculosis by Text Mining Platform of Artificial Intelligence using Open-Source Tool Orange Canvas
The Chinese Journal of Artificial Intelligence Editorial [Tuberculosis Drugs and Drug Targets]
Infectious Disorders - Drug Targets A Review of Antimycobacterial Drugs in Development
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic:Protein targets for development of drugs against Mycobacterium tuberculosis (Guest Editor: Walter Filgueira de Azevedo)]
Current Medicinal Chemistry Tuberculosis: Current Treatment and New Drug Development
Anti-Infective Agents in Medicinal Chemistry Mechanisms of Plant Defense Under Pathogen Stress: A Review
Current Protein & Peptide Science Live Recombinant Vectors for AIDS Vaccine Development
Current Molecular Medicine Editorial (Hot Topic : Computational Prediction of Drug-Target Interactions in Medicinal Chemistry)
Current Topics in Medicinal Chemistry Vanadium Complexes with Hydrazone or Thiosemicarbazone Ligands as Potential Anti-Mycobacterium tuberculosis Agents
Current Clinical Pharmacology Medicinal Chemistry Discoveries among 1,3,5-Triazines: Recent Advances (2000-2013) as Antimicrobial, Anti-TB, Anti-HIV and Antimalarials
Mini-Reviews in Medicinal Chemistry Peptidylprolyl Cis / Trans Isomerases (Immunophilins): Biological Diversity - Targets - Functions
Current Topics in Medicinal Chemistry Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Th2 Cytokines in Susceptibility to Tuberculosis
Current Molecular Medicine Pyrazoles and Fused Pyrimidines: Synthesis, Structure Elucidation, Antitubercular Activity and Molecular Docking Study
Medicinal Chemistry Oral Mucosal Immunization: Recent Advancement and Future Prospects
Current Immunology Reviews (Discontinued) 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules
Mini-Reviews in Medicinal Chemistry Ligand Docking and Structure-based Virtual Screening in Drug Discovery
Current Topics in Medicinal Chemistry Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole
Current Bioactive Compounds Editorial [Hot Topic: Protein Peptide Informatics and Drug Designing - Some Computational Techniques for Structural Genomics Based Approaches (Part II) (Guest Editor: Rajani R. Joshi)]
Protein & Peptide Letters